Delivery Order SPE2DR25D2205-SPE2DR26F2H44
Award Date 3/9/26
Potential Completion Date 3/30/26
Potential Value $37K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 24, 2026, for Takhzyro 300 mg/2 mL syringes with a ceiling value of $18,640.57. Place of performance is Conshohocken, PA. The order has a firm fixed price structure and an ultimate completion date of March 17, 2026. This delivery order was issued under the company's Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which supplies...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for Takhzyro 300 mg/2 ml syringe, 2 ml, with a ceiling value of $18,640.57.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 4, 2026. No set-aside was used.</p>
- The Defense Logistics Agency awarded a $31,755 delivery order to Amerisourcebergen Drug Corporation for TAKHZYRO 300 MG/2 ML syringes. Under the firm fixed price contract, Amerisourcebergen will deliver the specified pharmaceutical product to a location in Conshohocken, Pennsylvania by August 29, 2023 in support of DLA programs. No additional details were provided regarding the original solicitation or use of the products. Amerisourcebergen will perform as the prime contractor for this order...
- The Defense Logistics Agency awarded a $34,342.56 delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Takhzyro 300 mg/2 ml syringes. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award through open competition. Performance is scheduled for completion by August 6, 2025, and will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Takhzyro 300 mg/2 mL syringes with a ceiling value of $171,712.70. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 16, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $34,342.56 to AmerisourceBergen Drug Corp for the supply of Takhzyro 300 mg/2 mL syringes on September 15, 2025. This firm fixed-price, competitively awarded contract represents a non-set-aside procurement and is scheduled for completion by October 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $32,448.80 to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The contract is for the provision of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product, with a completion date of March 18, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $34,342.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Takhzyro 300 mg/2 ml syringes on April 25, 2025, with completion required by May 16, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively granted with no set-aside designation, and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TAKHZYRO 300 MG/2 ML SYRINGE 2ML. The contract is a delivery order with a firm fixed price of $48,673.20 and an ultimate completion date of August 29, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $34,342.56 and a performance period ending on July 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F2H44Delivery Order
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for TAKHZYRO 300 mg/2 ml syringe with a ceiling value of $37,281.14. The order is placed under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 running through December 2026. Place of performance is Conshohocken, PA. The ultimate completion date is March 30, 2026. Pricing is firm fixed price, and no set-aside was used.
Generated 6/7/26, 10:04 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.3k | 3/8/26 |